Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine)

Salix Sales Force to Begin Promoting LUCEMYRA to Primary Care and Pain Management Physicians LUCEMYRA is the First and Only Non-Opioid Medication Approved for Mitigation of Opioid Withdrawal Symptoms 08:00 ET from US WorldMeds LOUISVILLE, Ky. and... Biopharmaceuticals, Distribution US WorldMeds, Salix Pharmaceuticals, LUCEMYRA, lofexidine, Opioid Withdrawal
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news